EP 196: A new vision for sequencing: In-sample multiomics and precision medicine with Molly He

<p>This week on The Genetics Podcast, Patrick is joined by Molly He, CEO and co-founder of Element Biosciences. They discuss the current landscape of sequencing technologies, Element’s innovative sequencing platform, and the potential of using in-sample multiomic profiling across different stages of drug discovery. </p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>00:59</strong> Welcome to Molly</p><p><strong>01:42</strong> Persistent barriers in precision medicine</p><p><strong>04:54 </strong>Limitations of multiomics technologies and the unique advantage of Element’s approach</p><p><strong>07:33</strong> How Element started by inventing an ambitious sequencing instrument</p><p><strong>11:33 </strong>Overview of the chemistry behind Element’s sequencing technology</p><p><strong>14:41 </strong>Sequencing workflow of Element’s technology and technical advantages</p><p><strong>18:24 </strong>Sequencing inside cells and drug disco...